These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3059080)
1. Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy. Ross DS Mayo Clin Proc; 1988 Dec; 63(12):1223-9. PubMed ID: 3059080 [TBL] [Abstract][Full Text] [Related]
2. Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine. Banovac K; Papic M; Bilsker MS; Zakarija M; McKenzie JM Arch Intern Med; 1989 Apr; 149(4):809-12. PubMed ID: 2495780 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of iatrogenic hyperthyroidism in a community hospital. Watsky JG; Koeniger MA J Am Board Fam Pract; 1998; 11(3):175-9. PubMed ID: 9625507 [TBL] [Abstract][Full Text] [Related]
4. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function]. Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349 [TBL] [Abstract][Full Text] [Related]
5. Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Ross DS Am J Med; 1993 Oct; 95(4):385-8. PubMed ID: 8213870 [TBL] [Abstract][Full Text] [Related]
6. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation. Szabolcs I; Ploenes C; Bernard W; Herrmann J Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111 [TBL] [Abstract][Full Text] [Related]
7. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Ross DS; Neer RM; Ridgway EC; Daniels GH Am J Med; 1987 Jun; 82(6):1167-70. PubMed ID: 3605133 [TBL] [Abstract][Full Text] [Related]
8. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340 [TBL] [Abstract][Full Text] [Related]
11. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Biondi B; Cooper DS Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821 [TBL] [Abstract][Full Text] [Related]
12. Use of a sensitive thyrotropin assay for monitoring treatment with levothyroxine. Watts NB Arch Intern Med; 1989 Feb; 149(2):309-12. PubMed ID: 2644903 [TBL] [Abstract][Full Text] [Related]
13. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. Ross DS; Ardisson LJ; Nussbaum SR; Meskell MJ J Clin Endocrinol Metab; 1991 Feb; 72(2):507-9. PubMed ID: 1991818 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256 [TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Laurberg P; Andersen S; Bülow Pedersen I; Carlé A Drugs Aging; 2005; 22(1):23-38. PubMed ID: 15663347 [TBL] [Abstract][Full Text] [Related]
16. Clinical value of a sensitive immunoradiometric assay for TSH. Allen KR; Scott RD; Hewitt JV; Watson D Ann Clin Biochem; 1985 Sep; 22 ( Pt 5)():506-8. PubMed ID: 4062219 [TBL] [Abstract][Full Text] [Related]
17. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. Franklyn JA; Black EG; Betteridge J; Sheppard MC J Clin Endocrinol Metab; 1994 Jun; 78(6):1368-71. PubMed ID: 8200938 [TBL] [Abstract][Full Text] [Related]
18. Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement. Gow SM; Caldwell G; Toft AD; Seth J; Hussey AJ; Sweeting VM; Beckett GJ J Clin Endocrinol Metab; 1987 Feb; 64(2):364-70. PubMed ID: 3793854 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine. Zulewski H; Siggelkow H; Walden C; Becker W; Hüfner M Exp Clin Endocrinol Diabetes; 1999; 107(3):190-4. PubMed ID: 10376444 [TBL] [Abstract][Full Text] [Related]
20. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer. Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]